eprintid: 10190430
rev_number: 7
eprint_status: archive
userid: 699
dir: disk0/10/19/04/30
datestamp: 2024-04-10 15:29:14
lastmod: 2024-04-10 15:29:14
status_changed: 2024-04-10 15:29:14
type: article
metadata_visibility: show
sword_depositor: 699
creators_name: Englman, Cameron
creators_name: Maffei, Davide
creators_name: Allen, Clare
creators_name: Kirkham, Alex
creators_name: Albertsen, Peter
creators_name: Kasivisvanathan, Veeru
creators_name: Baroni, Ronaldo Hueb
creators_name: Briganti, Alberto
creators_name: De Visschere, Pieter
creators_name: Dickinson, Louise
creators_name: Gómez Rivas, Juan
creators_name: Haider, Masoom A
creators_name: Kesch, Claudia
creators_name: Loeb, Stacy
creators_name: Macura, Katarzyna J
creators_name: Margolis, Daniel
creators_name: Mitra, Anita M
creators_name: Padhani, Anwar R
creators_name: Panebianco, Valeria
creators_name: Pinto, Peter A
creators_name: Ploussard, Guillaume
creators_name: Puech, Philippe
creators_name: Purysko, Andrei S
creators_name: Radtke, Jan Philipp
creators_name: Rannikko, Antti
creators_name: Rastinehad, Art
creators_name: Renard-Penna, Raphaele
creators_name: Sanguedolce, Francesco
creators_name: Schimmöller, Lars
creators_name: Schoots, Ivo G
creators_name: Shariat, Shahrokh F
creators_name: Schieda, Nicola
creators_name: Tempany, Clare M
creators_name: Turkbey, Baris
creators_name: Valerio, Massimo
creators_name: Villers, Arnauld
creators_name: Walz, Jochen
creators_name: Barrett, Tristan
creators_name: Giganti, Francesco
creators_name: Moore, Caroline M
title: PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer
ispublished: inpress
divisions: UCL
divisions: B02
divisions: C10
divisions: D16
keywords: Active surveillance, Consensus, Prostate cancer, Prostate magnetic resonance imaging
note: This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
abstract: BACKGROUND AND OBJECTIVE: The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) recommendations standardise the reporting of prostate magnetic resonance imaging (MRI) in patients on active surveillance (AS) for prostate cancer. An international consensus group recently updated these recommendations and identified the areas of uncertainty. METHODS: A panel of 38 experts used the formal RAND/UCLA Appropriateness Method consensus methodology. Panellists scored 193 statements using a 1-9 agreement scale, where 9 means full agreement. A summary of agreement, uncertainty, or disagreement (derived from the group median score) and consensus (determined using the Interpercentile Range Adjusted for Symmetry method) was calculated for each statement and presented for discussion before individual rescoring. KEY FINDINGS AND LIMITATIONS: Participants agreed that MRI scans must meet a minimum image quality standard (median 9) or be given a score of 'X' for insufficient quality. The current scan should be compared with both baseline and previous scans (median 9), with the PRECISE score being the maximum from any lesion (median 8). PRECISE 3 (stable MRI) was subdivided into 3-V (visible) and 3-NonV (nonvisible) disease (median 9). Prostate Imaging Reporting and Data System/Likert ≥3 lesions should be measured on T2-weighted imaging, using other sequences to aid in the identification (median 8), and whenever possible, reported pictorially (diagrams, screenshots, or contours; median 9). There was no consensus on how to measure tumour size. More research is needed to determine a significant size increase (median 9). PRECISE 5 was clarified as progression to stage ≥T3a (median 9). CONCLUSIONS AND CLINICAL IMPLICATIONS: The updated PRECISE recommendations reflect expert consensus opinion on minimal standards and reporting criteria for prostate MRI in AS. PATIENT SUMMARY: The Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) recommendations are used in clinical practice and research to guide the interpretation and reporting of magnetic resonance imaging for patients on active surveillance for prostate cancer. An international panel has updated these recommendations, clarified the areas of uncertainty, and highlighted the areas for further research.
date: 2024-03-30
date_type: published
publisher: Elsevier BV
official_url: http://dx.doi.org/10.1016/j.eururo.2024.03.014
oa_status: green
full_text_type: pub
language: eng
primo: open
primo_central: open_green
verified: verified_manual
elements_id: 2266473
doi: 10.1016/j.eururo.2024.03.014
pii: S0302-2838(24)02232-2
lyricists_name: Giganti, Francesco
lyricists_id: FGIGA51
actors_name: Flynn, Bernadette
actors_id: BFFLY94
actors_role: owner
full_text_status: public
publication: European Urology
event_location: Switzerland
citation:        Englman, Cameron;    Maffei, Davide;    Allen, Clare;    Kirkham, Alex;    Albertsen, Peter;    Kasivisvanathan, Veeru;    Baroni, Ronaldo Hueb;                                                                                                                                     ... Moore, Caroline M; + view all <#>        Englman, Cameron;  Maffei, Davide;  Allen, Clare;  Kirkham, Alex;  Albertsen, Peter;  Kasivisvanathan, Veeru;  Baroni, Ronaldo Hueb;  Briganti, Alberto;  De Visschere, Pieter;  Dickinson, Louise;  Gómez Rivas, Juan;  Haider, Masoom A;  Kesch, Claudia;  Loeb, Stacy;  Macura, Katarzyna J;  Margolis, Daniel;  Mitra, Anita M;  Padhani, Anwar R;  Panebianco, Valeria;  Pinto, Peter A;  Ploussard, Guillaume;  Puech, Philippe;  Purysko, Andrei S;  Radtke, Jan Philipp;  Rannikko, Antti;  Rastinehad, Art;  Renard-Penna, Raphaele;  Sanguedolce, Francesco;  Schimmöller, Lars;  Schoots, Ivo G;  Shariat, Shahrokh F;  Schieda, Nicola;  Tempany, Clare M;  Turkbey, Baris;  Valerio, Massimo;  Villers, Arnauld;  Walz, Jochen;  Barrett, Tristan;  Giganti, Francesco;  Moore, Caroline M;   - view fewer <#>    (2024)    PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.                   European Urology        10.1016/j.eururo.2024.03.014 <https://doi.org/10.1016/j.eururo.2024.03.014>.    (In press).    Green open access   
 
document_url: https://discovery-pp.ucl.ac.uk/id/eprint/10190430/1/1-s2.0-S0302283824022322-main.pdf